価格表

在庫・価格 : 2024年06月03日 05時21分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Influenza A virus H1N1 HA (Hemagglutinin), Rabbit
データシート
GTX127357 GNTジーンテックス
GeneTex International Corporation
25 μl ¥24,000 1個 追加

在庫・価格 : 2024年06月03日 05時21分 現在

Anti-Influenza A virus H1N1 HA (Hemagglutinin), Rabbit

  • 商品コード:GTX127357
  • メーカー:GNT
  • 包装:25μl
  • 価格: ¥24,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Xia C et al. Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1. J. Virol. 2015 Dec;90(5):2403-17
Xia C et al
2015/01/01
PubMed
2 Hu Y et al. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses. Antiviral Res. 2017 Sep;145:103-113
Hu Y et al
2017/01/01
Application: Western blot PubMed
3 Watanabe K et al. Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction. Sci Rep 2017 Aug;7(1):9500
Watanabe K et al
2017/01/01
Application: Western Blot (WB) PubMed
4 Kuss-Duerkop SK et al. Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication. PLoS Pathog. 2017 Sep;13(9):e1006635
Kuss-Duerkop SK et al
2017/01/01
PubMed
5 Su WC et al. Ubiquitination of the Cytoplasmic Domain of Influenza A Virus M2 Protein Is Crucial for Production of Infectious Virus Particles. J. Virol. 2018 02;92(4)
Su WC et al
2018/01/01
PubMed
6 Koczka K et al. Comparative transcriptome analysis of a Trichoplusia ni cell line reveals distinct host responses to intracellular and secreted protein products expressed by recombinant baculoviruses. J. Biotechnol. 2018 Mar;270:61-69
Koczka K et al
2018/01/01
Application: Western Blot (WB) PubMed
7 Xia C et al. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus. J. Virol. 2018 04;92(7)
Xia C et al
2018/01/01
Application: Western Blot (WB) PubMed
8 Canale AS et al. Synonymous Mutations at the Beginning of the Influenza A Virus Hemagglutinin Gene Impact Experimental Fitness. J. Mol. Biol. 2018 Apr;430(8):1098-1115
Canale AS et al
2018/01/01
Application: ELISA, Immunocytochemistry/ Immunofluorescence (ICC/IF) PubMed
9 Chida J et al. Prion protein protects mice from lethal infection with influenza A viruses. PLoS Pathog. 2018 05;14(5):e1007049
Chida J et al
2018/01/01
Application: Western Blot (WB) PubMed
10 Weisshaar M et al. Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening. J. Virol. 2016 08;90(16):7368-7387
Weisshaar M et al
2016/01/01
Application: Western Blot (WB) PubMed
11 Lin HT et al. Grail attenuates influenza A virus infection and pathogenesis by inhibiting viral nucleoprotein. Sci Rep 2018 Nov;8(1):17242
Lin HT et al
2018/01/01
Application: Western Blot PubMed
12 Mizuta S et al. Synthesis of Trifluoromethyl-α,β-unsaturated Lactones and Pyrazolinones and Discovery of Influenza Virus Polymerase Inhibitors. ChemMedChem 2018 Nov;13(22):2390-2399
Mizuta S et al
2018/01/01
Application: Western Blot PubMed
13 Zhang J et al. Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses. Eur J Pharm Sci 2019 May;133:86-94
Zhang J et al
2019/01/01
Application: Western Blot PubMed
14 Yuan S et al. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. Nat Commun 2019 01;10(1):120
Yuan S et al
2019/01/01
Application: Western Blot PubMed
15 Hong JY et al. Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development. Antiviral Res. 2019 Apr;164:12-22
Hong JY et al
2019/01/01
Application: Western Blot PubMed
16 Reiter K et al. Separation of influenza virus-like particles from baculovirus by polymer-grafted anion exchanger. J Sep Sci 2020 Jun;43(12):2270-2278
Reiter K et al
2020/01/01
PubMed
17 Omi J et al. The inducible amphisome isolates viral hemagglutinin and defends against influenza A virus infection. Nat Commun 2020 01;11(1):162
Omi J et al
2020/01/01
PubMed
18 Gadalla MR et al. Hemagglutinin of Influenza A, but not of Influenza B and C viruses is acylated by ZDHHC2, 8, 15 and 20. Biochem. J. 2020 01;477(1):285-303
Gadalla MR et al
2020/01/01
PubMed
19 Lee HS et al. Matrix Metalloproteinase-13 in Atherosclerotic Plaque Is Increased by Influenza A Virus Infection. J. Infect. Dis. 2020 01;221(2):256-266
Lee HS et al
2020/01/01
PubMed
20 Choi JG et al. Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition. Sci Rep 2019 08;9(1):12132
Choi JG et al
2019/01/01
PubMed
21 Zhang K et al. Structural basis for influenza virus NS1 protein block of mRNA nuclear export. Nat Microbiol 2019 10;4(10):1671-1679
Zhang K et al
2019/01/01
PubMed
22 Yang F et al. Discovery of a Novel Specific Inhibitor Targeting Influenza A Virus Nucleoprotein with Pleiotropic Inhibitory Effects on Various Steps of the Viral Life Cycle. J Virol 2021 04;95(9)
Yang F et al
2021/01/01
PubMed
23 Gadalla MR et al. NS1-mediated upregulation of ZDHHC22 acyltransferase in influenza a virus infected cells. Cell Microbiol 2021 Jun;23(6):e13322
Gadalla MR et al
2021/01/01
PubMed
24 Zhu Y et al. Human TRA2A determines influenza A virus host adaptation by regulating viral mRNA splicing. Sci Adv 2020 Jun;6(25):eaaz5764
Zhu Y et al
2020/01/01
PubMed
25 Hara H et al. Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells. Sci Rep 2021 05;11(1):10109
Hara H et al
2021/01/01
PubMed
26 Zhao Y et al. <i>CMAS</i> and <i>ST3GAL4</i> Play an Important Role in the Adsorption of Influenza Virus by Affecting the Synthesis of Sialic Acid Receptors. Int J Mol Sci 2021 Jun;22(11)
Zhao Y et al
2021/01/01
PubMed
27 Chen Y et al. Quantitative and Ultrasensitive In-situ Immunoassay Technology for SARS-CoV-2 Detection in Saliva. Res Sq 2021 Jan;
Chen Y et al
2021/01/01
PubMed
28 Kaugars K et al. A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity. Proc Natl Acad Sci U S A 2021 Aug;118(34)
Kaugars K et al
2021/01/01
PubMed
29 Chen Y et al. Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva. Sci Adv 2022 May;8(21):eabn3481
Chen Y et al
2022/01/01
PubMed
30 WK Cho et al., Hoveniae Semen Seu Fructus water extract inhibits influenza A virus infection, J Funct ?Foods., 2024., 112()., 105940

PubMed
31 Wang X et al. Immunosuppressants exert antiviral effects against influenza A(H1N1)pdm09 virus via inhibition of nucleic acid synthesis, mRNA splicing, and protein stability. Virulence 2024 Dec;15(1):2301242
Wang X et al
2024/01/01
PubMed
32 Shi W et al. ABTB1 facilitates the replication of influenza A virus by counteracting TRIM4-mediated degradation of viral NP protein. Emerg Microbes Infect 2023 Dec;12(2):2270073
Shi W et al
2023/01/01
PubMed
33 Meng X et al. Palmitoylation of the hemagglutinin of influenza B virus by ER-localized DHHC enzymes 1, 2, 4, and 6 is required for efficient virus replication. J Virol 2023 Oct;97(10):e0124523
Meng X et al
2023/01/01
PubMed
34 Liu X et al. A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses. NPJ Vaccines 2023 Sep;8(1):132
Liu X et al
2023/01/01
PubMed
35 Zhao Z et al. Host DNA Demethylation Induced by DNMT1 Inhibition Up-Regulates Antiviral OASL Protein during Influenza a Virus Infection. Viruses 2023 Jul;15(8)
Zhao Z et al
2023/01/01
PubMed
36 Thomas SN et al. Down syndrome is associated with altered frequency and functioning of tracheal multiciliated cells, and response to influenza virus infection. iScience 2023 Aug;26(8):107361
Thomas SN et al
2023/01/01
PubMed
37 Gao P et al. Apolipoprotein E mediates cell resistance to influenza virus infection. Sci Adv 2022 Sep;8(38):eabm6668
Gao P et al
2022/01/01
PubMed
38 Ye Q et al. Rational development of a combined mRNA vaccine against COVID-19 and influenza. NPJ Vaccines 2022 Jul;7(1):84
Ye Q et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Xia C et al. Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1. J. Virol. 2015 Dec;90(5):2403-17
    Xia C et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Hu Y et al. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses. Antiviral Res. 2017 Sep;145:103-113
    Hu Y et al
    2017/01/01
  • 備考:
    Application: Western blot
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Watanabe K et al. Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction. Sci Rep 2017 Aug;7(1):9500
    Watanabe K et al
    2017/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kuss-Duerkop SK et al. Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication. PLoS Pathog. 2017 Sep;13(9):e1006635
    Kuss-Duerkop SK et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Su WC et al. Ubiquitination of the Cytoplasmic Domain of Influenza A Virus M2 Protein Is Crucial for Production of Infectious Virus Particles. J. Virol. 2018 02;92(4)
    Su WC et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Koczka K et al. Comparative transcriptome analysis of a Trichoplusia ni cell line reveals distinct host responses to intracellular and secreted protein products expressed by recombinant baculoviruses. J. Biotechnol. 2018 Mar;270:61-69
    Koczka K et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Xia C et al. Casein Kinase 1&#x3B1; Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus. J. Virol. 2018 04;92(7)
    Xia C et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Canale AS et al. Synonymous Mutations at the Beginning of the Influenza A Virus Hemagglutinin Gene Impact Experimental Fitness. J. Mol. Biol. 2018 Apr;430(8):1098-1115
    Canale AS et al
    2018/01/01
  • 備考:
    Application: ELISA, Immunocytochemistry/ Immunofluorescence (ICC/IF)
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Chida J et al. Prion protein protects mice from lethal infection with influenza A viruses. PLoS Pathog. 2018 05;14(5):e1007049
    Chida J et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Weisshaar M et al. Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening. J. Virol. 2016 08;90(16):7368-7387
    Weisshaar M et al
    2016/01/01
  • 備考:
    Application: Western Blot (WB)
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Lin HT et al. Grail attenuates influenza A virus infection and pathogenesis by inhibiting viral nucleoprotein. Sci Rep 2018 Nov;8(1):17242
    Lin HT et al
    2018/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Mizuta S et al. Synthesis of Trifluoromethyl-&#x3B1;,&#x3B2;-unsaturated Lactones and Pyrazolinones and Discovery of Influenza Virus Polymerase Inhibitors. ChemMedChem 2018 Nov;13(22):2390-2399
    Mizuta S et al
    2018/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Zhang J et al. Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses. Eur J Pharm Sci 2019 May;133:86-94
    Zhang J et al
    2019/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Yuan S et al. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. Nat Commun 2019 01;10(1):120
    Yuan S et al
    2019/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Hong JY et al. Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development. Antiviral Res. 2019 Apr;164:12-22
    Hong JY et al
    2019/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Reiter K et al. Separation of influenza virus-like particles from baculovirus by polymer-grafted anion exchanger. J Sep Sci 2020 Jun;43(12):2270-2278
    Reiter K et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Omi J et al. The inducible amphisome isolates viral hemagglutinin and defends against influenza A virus infection. Nat Commun 2020 01;11(1):162
    Omi J et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Gadalla MR et al. Hemagglutinin of Influenza A, but not of Influenza B and C viruses is acylated by ZDHHC2, 8, 15 and 20. Biochem. J. 2020 01;477(1):285-303
    Gadalla MR et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Lee HS et al. Matrix Metalloproteinase-13 in Atherosclerotic Plaque Is Increased by Influenza A Virus Infection. J. Infect. Dis. 2020 01;221(2):256-266
    Lee HS et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Choi JG et al. Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition. Sci Rep 2019 08;9(1):12132
    Choi JG et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Zhang K et al. Structural basis for influenza virus NS1 protein block of mRNA nuclear export. Nat Microbiol 2019 10;4(10):1671-1679
    Zhang K et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Yang F et al. Discovery of a Novel Specific Inhibitor Targeting Influenza A Virus Nucleoprotein with Pleiotropic Inhibitory Effects on Various Steps of the Viral Life Cycle. J Virol 2021 04;95(9)
    Yang F et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Gadalla MR et al. NS1-mediated upregulation of ZDHHC22 acyltransferase in influenza a virus infected cells. Cell Microbiol 2021 Jun;23(6):e13322
    Gadalla MR et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Zhu Y et al. Human TRA2A determines influenza A virus host adaptation by regulating viral mRNA splicing. Sci Adv 2020 Jun;6(25):eaaz5764
    Zhu Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Hara H et al. Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells. Sci Rep 2021 05;11(1):10109
    Hara H et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Zhao Y et al. <i>CMAS</i> and <i>ST3GAL4</i> Play an Important Role in the Adsorption of Influenza Virus by Affecting the Synthesis of Sialic Acid Receptors. Int J Mol Sci 2021 Jun;22(11)
    Zhao Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Chen Y et al. Quantitative and Ultrasensitive In-situ Immunoassay Technology for SARS-CoV-2 Detection in Saliva. Res Sq 2021 Jan;
    Chen Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Kaugars K et al. A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity. Proc Natl Acad Sci U S A 2021 Aug;118(34)
    Kaugars K et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Chen Y et al. Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva. Sci Adv 2022 May;8(21):eabn3481
    Chen Y et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    WK Cho et al., Hoveniae Semen Seu Fructus water extract inhibits influenza A virus infection, J Funct ?Foods., 2024., 112()., 105940

  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Wang X et al. Immunosuppressants exert antiviral effects against influenza A(H1N1)pdm09 virus via inhibition of nucleic acid synthesis, mRNA splicing, and protein stability. Virulence 2024 Dec;15(1):2301242
    Wang X et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Shi W et al. ABTB1 facilitates the replication of influenza A virus by counteracting TRIM4-mediated degradation of viral NP protein. Emerg Microbes Infect 2023 Dec;12(2):2270073
    Shi W et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Meng X et al. Palmitoylation of the hemagglutinin of influenza B virus by ER-localized DHHC enzymes 1, 2, 4, and 6 is required for efficient virus replication. J Virol 2023 Oct;97(10):e0124523
    Meng X et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Liu X et al. A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses. NPJ Vaccines 2023 Sep;8(1):132
    Liu X et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Zhao Z et al. Host DNA Demethylation Induced by DNMT1 Inhibition Up-Regulates Antiviral OASL Protein during Influenza a Virus Infection. Viruses 2023 Jul;15(8)
    Zhao Z et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Thomas SN et al. Down syndrome is associated with altered frequency and functioning of tracheal multiciliated cells, and response to influenza virus infection. iScience 2023 Aug;26(8):107361
    Thomas SN et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Gao P et al. Apolipoprotein E mediates cell resistance to influenza virus infection. Sci Adv 2022 Sep;8(38):eabm6668
    Gao P et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Ye Q et al. Rational development of a combined mRNA vaccine against COVID-19 and influenza. NPJ Vaccines 2022 Jul;7(1):84
    Ye Q et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed